Project Grant K99GM158711
- Federal Project Grant Award Summary The University of Wisconsin–Madison received a $116,005 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded May 1, 2026, with completion targeted for April 30, 2028. The award supports research investigating molecular mechanisms that regulate neutrophil reverse migration during wound healing. The study aims to identify key neutrophil subpopulations...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Wisconsin - Madison a Project Grant totaling $580,507 under the Biomedical Research and Research Training program (CFDA 93.859) on May 6, 2026, with completion scheduled for February 28, 2031. This five-year research initiative investigates the mechanisms governing midbody remnants (MBRs)—large extracellular vesicles released during cell division—as novel mediators of...
- Federal Project Grant Award Summary The University of Utah received a $392,942 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 22, 2026 through February 28, 2030. The award supports investigator-initiated research examining the regulation of single cell migration in vivo, specifically focusing on the organization and dynamic regulation of focal adhesions during cellular...
- Federal Project Grant Award Summary The Medical College of Wisconsin, Inc. received a $390,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded April 1, 2026, with a completion date of March 31, 2031. This five-year investigator-initiated research project, titled "Metabolic Regulation of Immunity in C. Elegans," delivers fundamental biomedical research aimed at...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Wisconsin-Madison $413,001 under the Biomedical Research and Research Training program (CFDA 93.859) through an R35 Maximizing Investigators' Research Award (MIRA) effective April 1, 2026, with completion targeted for February 28, 2031. This award funds the development of computational systems and software tools designed to address critical analytical challenges in single-cell...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Georgia Research Foundation, Inc. a Project Grant of $189,854.00 under the Biomedical Research and Research Training program (CFDA 93.859) effective August 8, 2025, with a completion date of July 31, 2028. This award supports research to unravel the connection between cell deformability and motility in eukaryotic cells through development of an integrated in vitro and computational...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $483,175 to Washington University's Office of Sponsored Research Services (via CFDA 93.859, Biomedical Research and Research Training) effective June 1, 2026, through January 1, 2031. The research program investigates mechanosensitive mechanisms that regulate cellular transcription and cell-to-cell signaling during tissue morphogenesis and patterning. The project specifically examines how...
- Summary of Federal Project Grant Award The National Institute of General Medical Sciences (NIGMS) awarded a $374,550 Project Grant to the Seattle Institute for Biomedical and Clinical Research on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859). This five-year award, with a completion date of March 31, 2031, funds fundamental research into the molecular regulation of endothelial glycocalyx-mediated transcytosis—specifically investigating how...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Wisconsin–Madison a $418,331 Project Grant effective July 1, 2026, through May 31, 2031, under the Biomedical Research and Research Training program (CFDA 93.859). This award supports the development of advanced statistical methods for microbiome data analysis to address critical methodological challenges in large consortium-based microbiome studies. The project will deliver three...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) awarded $414,305 to the University of Wisconsin–Madison effective March 1, 2026, through February 28, 2031. This five-year Project Grant supports the development and implementation of advanced statistical genetics tools to address critical methodological challenges in drug target discovery and treatment optimization. The research program...
The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $124,929 to the University of Wisconsin-Madison, effective July 1, 2026 through June 30, 2028, under the Biomedical Research and Research Training program (CFDA 93.859). This award funds fundamental research investigating how epithelial tissue architecture regulates leukocyte migration strategies in vivo. The research employs intravital imaging in zebrafish models to characterize how cellular confinement within epithelial layers drives mechanosensitive signaling and distinct migration modes, including stable bleb migration and head-to-tail collective leukocyte streaming. The project incorporates optical metabolic imaging to elucidate the bioenergetic requirements of bleb-based motility and utilizes zebrafish mutants with altered epithelial confinement and disrupted PIEZO1 mechanosensitive ion channel function to establish mechanistic connections between tissue architecture and cell migration behavior. The research addresses fundamental gaps in cell migration biology with direct relevance to wound healing, immune defense, and understanding dysregulated migration in inflammatory disorders and cancer metastasis. As a K99/R00 Transition Award structure, the project advances early-stage investigator research through structured progression from foundational mechanistic studies to independent investigation of novel collective migration phenomena. The deliverables include peer-reviewed publications, experimental datasets characterizing leukocyte migration dynamics in confined epithelial environments, and mechanistic insights into how tissue geometry and mechanotransduction regulate cellular behavior in vivo.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $124.9k | 6/24/26 |